Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381041 | 12538104 | 1 | I | 20160630 | 20160707 | 20160707 | EXP | GR-PFM-GR-2016-2102 | PIERRE FABRE MEDICAMENT | 0.00 | F | Y | 0.00000 | 20160707 | CN | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381041 | 12538104 | 1 | PS | NAVELBINE | VINORELBINE TARTRATE | 1 | Unknown | U | 20388 | ||||||||||
| 125381041 | 12538104 | 2 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 4 | SS | EPIRUBICIN HYDROCHLORIDE. | EPIRUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 5 | SS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 6 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 8 | SS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK, WEEKLY | U | 0 | |||||||||
| 125381041 | 12538104 | 9 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 10 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 11 | SS | FASLODEX | FULVESTRANT | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 12 | SS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 13 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 14 | SS | Liposomal doxorubicin hydrochloride | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 15 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 16 | SS | ABRAXANE | PACLITAXEL | 1 | Unknown | U | 0 | ||||||||||
| 125381041 | 12538104 | 17 | SS | Eribulin | ERIBULIN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125381041 | 12538104 | 1 | Breast cancer metastatic |
| 125381041 | 12538104 | 2 | Breast cancer metastatic |
| 125381041 | 12538104 | 3 | Breast cancer metastatic |
| 125381041 | 12538104 | 4 | Breast cancer metastatic |
| 125381041 | 12538104 | 5 | Breast cancer metastatic |
| 125381041 | 12538104 | 6 | Breast cancer metastatic |
| 125381041 | 12538104 | 7 | Breast cancer metastatic |
| 125381041 | 12538104 | 8 | Breast cancer metastatic |
| 125381041 | 12538104 | 9 | Breast cancer metastatic |
| 125381041 | 12538104 | 10 | Breast cancer metastatic |
| 125381041 | 12538104 | 11 | Breast cancer metastatic |
| 125381041 | 12538104 | 12 | Breast cancer metastatic |
| 125381041 | 12538104 | 13 | Breast cancer metastatic |
| 125381041 | 12538104 | 14 | Breast cancer metastatic |
| 125381041 | 12538104 | 15 | Breast cancer metastatic |
| 125381041 | 12538104 | 16 | Breast cancer metastatic |
| 125381041 | 12538104 | 17 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125381041 | 12538104 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125381041 | 12538104 | Acute lymphocytic leukaemia | |
| 125381041 | 12538104 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |